42 forecasters

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

67%chance

Forecast Timeline

No key factors yetAdd some that might influence this forecast.

Add key factor

Authors:

Opened:

Nov 24, 2021

Closes:

Jan 1, 2029

Scheduled resolution:

Jan 1, 2029

Spot Scoring Time:

Nov 26, 2021

Health & Pandemics

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

PBS NewsHour•Sep 17, 2025

Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots

CNBC•Sep 17, 2025

New Alzheimer’s trial explores if weight-loss ingredient could help fight disease

Independent•Sep 17, 2025

Learn more about Metaculus NewsMatch